Cancer Trials Should Include Patients Who Haven’t Received Prior Treatment
July 30, 2021
The FDA issued draft guidance June 24 for trial investigators and sponsors, recommending that patients with incurable cancers be considered for oncology trials regardless of whether they have received existing alternative treatment options.